about
Positron Emission Tomography in Breast CancerRecurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkersClinical oncologic applications of PET/MRI: a new horizon.Initial experience of MR/PET in a clinical cancer center.PET/MRI in lung cancer.Positron emission tomography/magnetic resonance imaging of the breast.The impact of orthopedic metal artifact reduction software on interreader variability when delineating areas of interest in the head and neck.Image Quality and Diagnostic Performance of a Digital PET Prototype in Patients with Oncologic Diseases: Initial Experience and Comparison with Analog PET.18F-FDG positron emission tomography in oncology: main indications.[Positron emission tomography/magnetic resonance: Present and future].Performance Characteristics of the Whole-Body Discovery IQ PET/CT System.Optimization of the protocols for the use of contrast agents in PET/CT studies.Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.18F-FDG PET/CT in the detection of a primary radiation-induced metastatic angiosarcoma.Tumor volume delineation: A pilot study comparing a digital positron-emission tomography prototype with an analog positron-emission tomography system[Visualisation of prostate cancer liver metastases on a 99mTc-MDP bone scan][Effective doses associated to the usual multimodal examinations in nuclear medicine][Recurrence of hyperthyroidism in a female patient with thyroidectomized Grave's disease diagnosed 15 years earlier]Phantom, clinical, and texture indices evaluation and optimization of a penalized-likelihood image reconstruction method (Q.Clear) on a BGO PET/CT scannerDiagnostic Accuracy of 18F-FDG PET/CT in Patients With Biochemical Evidence of Recurrent, Residual, or Metastatic Medullary Thyroid Carcinoma
P50
Q26768486-37E7C7CB-195D-4990-9000-9992B629D235Q27014899-177FF9D6-61CA-44D2-9E71-C867BBE732FEQ37711076-C40808D6-2A1C-42F8-A0BE-011F8B21E258Q38134357-E4E5B11C-E95D-4D5B-8EF8-5D7307162C45Q38286658-6EC8C2EA-8692-4186-BEF5-C7F9921E8283Q38286660-0BB686F9-10AC-48A2-A816-939A33E3F28CQ38350142-14090397-63BA-41A7-9BCC-54204664B3F0Q40295066-3DA0099B-8D6A-44BC-88E2-EE9AF95FC763Q40672599-FA47F357-ECB3-4790-B8CB-0E0EE7F3E9B4Q46969286-0D761EC0-9253-4F3F-9A06-A1E43EDD5CE5Q47926538-4F834D74-3387-47CC-82E0-7FACC025C16FQ51443891-9F149E79-56C9-46A3-A1A0-FEE215596617Q53063148-ED3911F5-B759-4002-802E-492870B76238Q53793818-B512F3FD-0E0C-4AA2-A4D6-26A39E9680D0Q61810784-4F68F54C-7AE9-442D-9FB3-14304997E069Q83752397-C12ADFB9-0479-4C6E-B34D-364173B3102FQ84004685-CE0F5255-36E9-4BCF-A4A6-7AB36A84742FQ84796974-BC47D85D-1C4A-43E4-BBF5-FAF57B9825E5Q88757456-C6C5EA51-0A64-4F0C-AAEC-C6985CE9AFA4Q90613718-871400AF-B95D-40A7-8C11-B0C013B4B2ED
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
J L Vercher Conejero
@en
J L Vercher Conejero
@nl
type
label
J L Vercher Conejero
@en
J L Vercher Conejero
@nl
prefLabel
J L Vercher Conejero
@en
J L Vercher Conejero
@nl
P31
P496
0000-0002-5091-4973